Skip to main content

Table 2 Medications of RA patients before the specimens were obtained

From: (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway

Drugs

The number of cases

No treatment

1

Taking non-steroidal anti-inflammatory drugs

28

Taking 1 disease modifying antirheumatic drug

4

Taking 2 disease modifying antirheumatic drug

17

Taking ≥ 3 disease modifying antirheumatic drug

4

Taking glucocorticoid

13

Taking biologics

3

  1. Disease modifying antirheumatic drugs include methotrexate, leflunomide, sulfasalazine, penicillamine, hydroxychloroquine, and some herb extracts such as total glucosides of paeony, tripterygium glycosides and the extract of Caulis Sinomenii. Dose of glucocorticoid equals to prednisone 2–10 mg daily. Biologics include Etanercept (2 cases) and Infliximab (1 case).
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us